118 related articles for article (PubMed ID: 1472380)
1. Making sense from antisense: a review of experimental data and developing ideas on sense--antisense peptide recognition.
Tropsha A; Kizer JS; Chaiken IM
J Mol Recognit; 1992 Jun; 5(2):43-54. PubMed ID: 1472380
[TBL] [Abstract][Full Text] [Related]
2. The possible role of sense and antisense peptide interactions in the generation and maintenance of the tertiary structure of a protein.
Okada H
Anticancer Res; 1998; 18(5D):3927-30. PubMed ID: 9854505
[TBL] [Abstract][Full Text] [Related]
3. Interactions and uses of antisense peptides in affinity technology.
Chaiken I
J Chromatogr; 1992 Apr; 597(1-2):29-36. PubMed ID: 1517330
[TBL] [Abstract][Full Text] [Related]
4. Making sense of antisense and interference.
Morrow T
Manag Care; 2003 Nov; 12(11):62-3. PubMed ID: 14666589
[No Abstract] [Full Text] [Related]
5. Characterization of domain-peptide interaction interface: a case study on the amphiphysin-1 SH3 domain.
Hou T; Zhang W; Case DA; Wang W
J Mol Biol; 2008 Feb; 376(4):1201-14. PubMed ID: 18206907
[TBL] [Abstract][Full Text] [Related]
6. Studies on T-cell receptors involved in experimental autoimmune encephalomyelitis using the complementary peptide recognition approach.
Xian CJ; Simmons RD; Willenborg DO; Vandenbark AA; Hashim GA; Carnegie PR
J Neurosci Res; 1995 Aug; 41(5):620-7. PubMed ID: 7563242
[TBL] [Abstract][Full Text] [Related]
7. Antisense homology boxes in C5a receptor and C5a anaphylatoxin: a new method for identification of potentially active peptides.
Baranyi L; Campbell W; Okada H
J Immunol; 1996 Nov; 157(10):4591-601. PubMed ID: 8906838
[TBL] [Abstract][Full Text] [Related]
8. Genetic coding algorithm for sense and antisense peptide interactions.
Štambuk N; Konjevoda P; Turčić P; Kövér K; Kujundžić RN; Manojlović Z; Gabričević M
Biosystems; 2018 Feb; 164():199-216. PubMed ID: 29107641
[TBL] [Abstract][Full Text] [Related]
9. Antisense peptide recognition of sense peptides: sequence simplification and evaluation of forces underlying the interaction.
Shai Y; Brunck TK; Chaiken IM
Biochemistry; 1989 Oct; 28(22):8804-11. PubMed ID: 2605221
[TBL] [Abstract][Full Text] [Related]
10. [Biosynthesis of human calcitonin and mini-proinsulin in bacterial cells in the form of hybrid proteins with corresponding antisense peptides and a metal-binding peptide].
Efimov VA; Buriakova AA; Fradkov AF; Chakhmakhcheva OG
Bioorg Khim; 1996 Jul; 22(7):503-9. PubMed ID: 8992955
[TBL] [Abstract][Full Text] [Related]
11. Interaction simulation of hERG K+ channel with its specific BeKm-1 peptide: insights into the selectivity of molecular recognition.
Yi H; Cao Z; Yin S; Dai C; Wu Y; Li W
J Proteome Res; 2007 Feb; 6(2):611-20. PubMed ID: 17269718
[TBL] [Abstract][Full Text] [Related]
12. [Synthesis and cloning of genes for the antisense peptides for human calcitonin and miniproinsulin].
Efimov VA; Aronova EA; Buriakova AA; Kalinkina AL; Letunova AB; Fradkov AF; Chakhmakhcheva OG
Bioorg Khim; 1994 Jul; 20(7):759-71. PubMed ID: 7993380
[TBL] [Abstract][Full Text] [Related]
13. The amino terminal domain of HIV-1 Rev is required for discrimination of the RRE from nonspecific RNA.
Daly TJ; Doten RC; Rusche JR; Auer M
J Mol Biol; 1995 Oct; 253(2):243-58. PubMed ID: 7563086
[TBL] [Abstract][Full Text] [Related]
14. Fos, Jun and CREB basic-domain peptides have intrinsic DNA-binding activity enhanced by a novel stabilizing factor.
Busch SJ; Sassone-Corsi P
Oncogene; 1990 Oct; 5(10):1549-56. PubMed ID: 2147467
[TBL] [Abstract][Full Text] [Related]
15. FinO is an RNA chaperone that facilitates sense-antisense RNA interactions.
Arthur DC; Ghetu AF; Gubbins MJ; Edwards RA; Frost LS; Glover JN
EMBO J; 2003 Dec; 22(23):6346-55. PubMed ID: 14633993
[TBL] [Abstract][Full Text] [Related]
16. Comparative structural and energetic analysis of WW domain-peptide interactions.
Schleinkofer K; Wiedemann U; Otte L; Wang T; Krause G; Oschkinat H; Wade RC
J Mol Biol; 2004 Nov; 344(3):865-81. PubMed ID: 15533451
[TBL] [Abstract][Full Text] [Related]
17. Protein-protein recognition: an experimental and computational study of the R89K mutation in Raf and its effect on Ras binding.
Zeng J; Fridman M; Maruta H; Treutlein HR; Simonson T
Protein Sci; 1999 Jan; 8(1):50-64. PubMed ID: 10210183
[TBL] [Abstract][Full Text] [Related]
18. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
Sadowsky JD; Fairlie WD; Hadley EB; Lee HS; Umezawa N; Nikolovska-Coleska Z; Wang S; Huang DC; Tomita Y; Gellman SH
J Am Chem Soc; 2007 Jan; 129(1):139-54. PubMed ID: 17199293
[TBL] [Abstract][Full Text] [Related]
19. Antisense peptides: a critical mini-review.
Root-Bernstein RS; Holsworth DD
J Theor Biol; 1998 Jan; 190(2):107-19. PubMed ID: 9538461
[TBL] [Abstract][Full Text] [Related]
20. The identification of conserved interactions within the SH3 domain by alignment of sequences and structures.
Larson SM; Davidson AR
Protein Sci; 2000 Nov; 9(11):2170-80. PubMed ID: 11152127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]